Two sets of studies for COVID-driven conditions show the struggles of drug development
Chemical & Engineering News (C&EN) Homepage
Here’s what we’re watching in the chemical and pharmaceutical industries this week
The agency’s decisions come as it starts implementing President Donald J. Trump’s June 25 executive order on regenerative agriculture, which calls for reducing reliance on ‘chemical crop protection tools’
His work has revealed a lack of transparency in fruit- and vegetable-based products
By undoing lysine glycation, Revel Pharmaceuticals hopes to address tissue stiffness, inflammation
His administration isn’t interested in slowing climate change, but it’s using industrial policy to achieve national security goals that overlap with Biden-era priorities
The program offers members of both science societies a more affordable way to access additional benefits
Chemists make simple amides using only inexpensive lab chemicals
Researchers used AI to create variants of a CRISPR-Cas12-like nuclease, some of which show increased editing activity
With a new head who minimizes climate change’s impact, the program has a murky future
Nanoscience expert honored for pioneering new nanomaterials, accelerating materials discovery, and creating advanced manufacturing technologies
A weekly roundup of policy news in the chemical arena and beyond
---452694:Widescreen?$responsive$&qlt=90,0&resMode=sharp2&fmt=webp)
---452445:Widescreen?$responsive$&qlt=90,0&resMode=sharp2&fmt=webp)
---444395:Widescreen?$responsive$&qlt=90,0&resMode=sharp2&fmt=webp)
The climate solution suffers from slow dissolution rates. This scientist turned to chemistry for a solution
A crossword highlighting national historic chemical landmarks
Test your knowledge of our stories on space chemistry, crustaceans, greenhouse gases, and more
Waterlogged, oxygen-poor conditions prevent destructive oxidation and stabilize certain proteins
The $2.8 billion deal brings a drug candidate for treatment-resistant depression
